601R-DOLLAR GENERAL - IBUPROFEN TABLETS 200 MG 55910-901
- Manufacturer
- DOLGENCORP INC | TIME CAP LABORATORIES, INC | MARKSANS PHARMA LIMITED
- Effective date
- 2023-01-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 23:52:54
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Ibuprofen 200 mg (NSAID)*
* nonstreoidal anti-inflammatory drug
INACTIVE INGREDIENT SECTION
Silicon dioxide, croscarmellose sodium, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, pregelatinized starch, talc, titanium dioxide.
OTC - PURPOSE SECTION
Pain reliever / fever reducer
INDICATIONS & USAGE SECTION
USE(S)
temporarily relieves minor aches and pains due to :
backache
headache
menstrual cramps
minor pain of arthritis
muscular aches
the common cold
toothache
temporarily reduces fever
WARNINGS SECTION
| WARNINGS Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin.
asthma (wheezing)
If an allergic reaction occurs, stop use and seek medical help right away.
are age 60 or older
Heart attack and stroke warning: NSAID's except aspirin increases the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or longer than directed. |
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS do not take more than directed
adults and children 12 years and older: take 1 tablet every 4 to 6 hours while symptoms persist
Children under 12 years: ask a doctor |
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| IBUPROFEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55910-901-42 | ibuprofen | 24 in 1 BOTTLE | TABLET, COATED | 24 | 3 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- ibuprofen
- CROSCARMELLOSE SODIUM
- CROSCARMELLOSE
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POLYVINYL ALCOHOL, UNSPECIFIED
- SILICON DIOXIDE
- FERRIC OXIDE RED
- MAGNESIUM STEARATE
- STARCH, CORN
- TALC
- TITANIUM DIOXIDE
- MICROCRYSTALLINE CELLULOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55910-901 | 55910-901-42 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| POLYVINYL ALCOHOL, UNSPECIFIED | 532B59J990 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| IBUPROFEN | WK2XYI10QM | ACTIB |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091239-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091239-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-01 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ibuprofen | IBUPROFEN | DOLGENCORP INC | 8f1358aa-495a-23da-e053-2995a90aa430 | 2023-01-02 | Warnings | 55910-901-42 55910-901 55910090142 f0b3ed7d-1622-3990-e053-2995a90ae520 8f1358aa-495a-23da-e053-2995a90aa430 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
